Long-term outcomes of Sleeping Beauty–generated CD19-specific CAR T-cell therapy for relapsed-refractory B-cell lymphomas-Reference-Cited by-同舟云学术

Long-term outcomes of Sleeping Beauty–generated CD19-specific CAR T-cell therapy for relapsed-refractory B-cell lymphomas

Published:2020-03-12 Issue:11 Volume:135 Page:862-865
ISSN:0006-4971
Container-title:Blood
language:en
Short-container-title:

Author:

Srour S. A.¹,Singh H.²^ORCID,McCarty J.¹,de Groot E.³,Huls H.²,Rondon G.¹,Qazilbash M.¹,Ciurea S.¹,Bardelli G.³,Buck J.³^ORCID,Alousi A.¹,Nieto Y.¹^ORCID,Rezvani K.¹,Marin D.¹,Popat U.¹^ORCID,Hosing C.¹,Shpall E. J.¹,Wierda W. G.⁴,Kantarjian H.⁴^ORCID,Champlin R. E.¹^ORCID,Cooper L. J.³,Kebriaei P.¹

Affiliation:

1. Department of Stem Cell Transplantation and Cellular Therapy and

2. Department of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX;

3. Ziopharm Oncology, Boston, MA; and

4. Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Link

http://ashpublications.org/blood/article-pdf/135/11/862/1718614/bloodbld2019002920.pdf

Reference11 articles.

1. Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin’s lymphoma;Philip;N Engl J Med,1995

2. Novel therapies for relapsed/refractory aggressive lymphomas;Cohen;Hematology (Am Soc Hematol Educ Program),2018

3. A randomized phase II study of standard-dose versus high-dose rituximab with BEAM in autologous stem cell transplantation for relapsed aggressive B-cell non-Hodgkin lymphomas: long term results;Srour;Br J Haematol,2017

4. Salvage regimens with autologous transplantation for relapsed large B-cell lymphoma in the rituximab era;Gisselbrecht;J Clin Oncol,2010

5. Outcomes in refractory diffuse large B-cell lymphoma: results from the international SCHOLAR-1 study;Crump;Blood,2017

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. iPS cell therapy 2.0: Preparing for next‐generation regenerative medicine;BioEssays;2024-06-25

2. Evolution of the clinical-stage hyperactive TcBuster transposase as a platform for robust non-viral production of adoptive cellular therapies;Molecular Therapy;2024-06

3. Empowering virus-free CAR immune cell therapies;Molecular Therapy;2024-06

4. A Naturally Active Spy Transposon Discovered from the Insect Genome of Colletes gigas as a Promising Novel Gene Transfer Tool;Advanced Science;2024-05-22

5. “Off the Shelf” CAR ‐T/ NK Cells;Precision Cancer Therapies vol 2 ‐ Immunologic Approaches for the Treatment of Lymphoid Malignancies ‐ From Concept to Practice;2024-02-21